![3-[(tert-Butoxycarbonyl)amino]-3-(3-hydroxyphenyl)propanoic acid - chemical structure image](https://media.scbt.com/product/3--tert-butoxycarbonyl-amino-3-3-hydroxyphenyl-propanoic-acid-structure_22_68_b_226897.jpg)
![3-[(tert-Butoxycarbonyl)amino]-3-(3-hydroxyphenyl)propanoic acid - chemical structure image](https://media.scbt.com/product/3--tert-butoxycarbonyl-amino-3-3-hydroxyphenyl-propanoic-acid-structure_22_68_t_226897.jpg "Molecular structure of 3-[(tert-Butoxycarbonyl)amino]-3-(3-hydroxyphenyl)propanoic acid")
3-[(tert-Butoxycarbonyl)amino]-3-(3-hydroxyphenyl)propanoic acid
QUICK LINKS
Cilastatin sodium is utilized in biochemical research to investigate the inhibition of human renal enzymes, particularly renal dehydropeptidase-1 (DHP-1). DHP-1 is involved in the metabolic breakdown of certain antibiotics, and cilastatin is studied for its ability to protect these compounds from enzymatic degradation. In experimental applications, researchers use cilastatin sodium to delve into the mechanisms of renal metabolism and to assess how the inhibition of DHP-1 can affect the kinetics and mechanisms of compounds simultaneously administered. This research has broader implications for improving chemical delivery systems and understanding renal clearance. Its use in research extends to the examination of kidney function and the exploration of how endogenous compounds are processed by renal pathways.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
3-[(tert-Butoxycarbonyl)amino]-3-(3-hydroxyphenyl)propanoic acid, 500 mg | sc-310601 | 500 mg | $296.00 | |||
3-[(tert-Butoxycarbonyl)amino]-3-(3-hydroxyphenyl)propanoic acid, 1 g | sc-310601A | 1 g | $400.00 |